Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro (Q73769171)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

main subject

lymphoblastic leukemia

1 reference

7

E S Vitetta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

L Herrera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R A Farah

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

V A Pellegrini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D B Aquino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E S Sandler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

G R Buchanan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

853-858

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10803517%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2401779

6 November 2019

exact match

0 references

cites work

Treatment of childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Immunotoxins in the therapy of cancer: from bench to clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Experimental treatment of human Hodgkin's disease with ricin A-chain immunotoxins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Selective killing of normal and neoplastic human B cells with anti-CD19- and anti-CD22-ricin A chain immunotoxins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Characterization of a leukemic cell line of the pre-B phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Growth requirements of normal and leukemic human B cell progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Cells and molecules that regulate B lymphopoiesis in bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Therapy of human B-cell lymphoma bearing SCID mice is more effective with anti-CD19- and anti-CD38-saporin immunotoxins used in combination than with either immunotoxin used alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401779

7 January 2021